Concepedia

Shoko Nakayama

SN

Statistics

Publications

13

Citations

274

H-Index

12

Active since

2009

Affiliations

Osaka Medical and Pharmaceutical University(Current)

Kindai University Hospital

Shoko Nakayama is an author at Osaka Medical and Pharmaceutical University specializing in medicine, oncology, and pathology.

ORCID

Publications per year

2009–2020

13

Publications

13

Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified

Shoko Nakayama, Taiji Yokote, Toshikazu Akioka et al. · Blood Advances · 2017 · 45 citations · Full text

, , +16

Role of mast cells in fibrosis of classical Hodgkin lymphoma

Shoko Nakayama, Taiji Yokote, Nobuya Hiraoka et al. · International Journal of Immunopathology and Pharmacology · 2016 · 40 citations · Full text

, , +17

TNF-α Expression in Tumor Cells as a Novel Prognostic Marker for Diffuse Large B-cell Lymphoma, Not Otherwise Specified

Shoko Nakayama, Taiji Yokote, Yuji Hirata et al. · The American Journal of Surgical Pathology · 2013 · 29 citations

, , +11

Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies

Yuji Hirata, Taiji Yokote, Kichinosuke Kobayashi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 25 citations

, , +17

Transforming growth factor β – and interleukin 13–producing mast cells are associated with fibrosis in bone marrow

Shoko Nakayama, Taiji Yokote, Nobuya Hiraoka et al. · Human Pathology · 2017 · 22 citations

, , +12

1–5 of 13